Nisa Investment Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.8K | Buy |
940
+35
| +4% | +$954 | ﹤0.01% | 1872 |
|
|
2025
Q4 | $24.6K | Sell |
905
-490
| -35% | -$12.9K | ﹤0.01% | 1865 |
|
|
2025
Q3 | $36.1K | Buy |
1,395
+1
| +0.1% | +$23 | ﹤0.01% | 1728 |
|
|
2025
Q2 | $28.4K | Buy |
1,394
+881
| +172% | +$17.1K | ﹤0.01% | 1776 |
|
|
2025
Q1 | $9.31K | Sell |
513
-31
| -6% | -$693 | ﹤0.01% | 2114 |
|
|
2024
Q4 | $13.7K | Sell |
544
-138
| -20% | -$3.75K | ﹤0.01% | 2049 |
|
|
2024
Q3 | $23.2K | Buy |
682
+35
| +5% | +$1.33K | ﹤0.01% | 1867 |
|
|
2024
Q2 | $23.9K | Sell |
647
-120,926
| -99% | -$4.56M | ﹤0.01% | 1883 |
|
|
2024
Q1 | $5.1M | Buy |
121,573
+121,043
| +22,838% | +$4.97M | 0.03% | 432 |
|
|
2023
Q4 | $21K | Sell |
530
-710
| -57% | -$20.9K | ﹤0.01% | 1866 |
|
|
2023
Q3 | $34.1K | Sell |
1,240
-14
| -1% | -$439 | ﹤0.01% | 1844 |
|
|
2023
Q2 | $42.5K | Buy |
1,254
+230
| +22% | +$7.75K | ﹤0.01% | 1801 |
|
|
2023
Q1 | $37K | Hold |
1,024
| – | – | ﹤0.01% | 1808 |
|
|
2022
Q4 | $46K | Hold |
1,024
| – | – | ﹤0.01% | 1801 |
|
|
2022
Q3 | $36K | Buy |
1,024
+534
| +109% | +$16.4K | ﹤0.01% | 1861 |
|
|
2022
Q2 | $13K | Sell |
490
-900
| -65% | -$26.1K | ﹤0.01% | 2143 |
|
|
2022
Q1 | $47K | Sell |
1,390
-822
| -37% | -$26.3K | ﹤0.01% | 1862 |
|
|
2021
Q4 | $69K | Sell |
2,212
-588
| -21% | -$25.6K | ﹤0.01% | 1634 |
|
|
2021
Q3 | $151 | Buy |
+2,800
| New | +$131K | ﹤0.01% | 1524 |
|
|
2016
Q2 | – | Sell |
-80
| Closed | -$5K | – | 1863 |
|
|
2016
Q1 | $5K | Sell |
80
-1,647
| -95% | -$185K | ﹤0.01% | 1839 |
|
|
2015
Q4 | $406K | Hold |
1,727
| – | – | 0.01% | 1015 |
|
|
2015
Q3 | $273K | Hold |
1,727
| – | – | ﹤0.01% | 1131 |
|
|
2015
Q2 | $653K | Hold |
1,727
| – | – | 0.01% | 930 |
|
|
2015
Q1 | $722K | Buy |
1,727
+80
| +5% | +$28.6K | 0.01% | 913 |
|
|
2014
Q4 | $451K | Hold |
1,647
| – | – | 0.01% | 1040 |
|
|
2014
Q3 | $320K | Buy |
+1,647
| New | +$359K | ﹤0.01% | 1132 |
|
Other funds holding CLDX
KCM
VCM
CC
EP